AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35832107 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonstimulated)
Number of subjects: 17
Study 35832107 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) stimulation
Number of subjects: 17
Study 35441200 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomecel-B (25, 50, 100, or 200 million cells)
Number of subjects: 150
Study 35441200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 35441200 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomecel-B
Number of subjects: 150
Study 32844599 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidafenacin 0.1 mg twice daily
Number of subjects: 118
Study 32844599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 33273421 — intervention group
Group type: EXPERIMENTAL
Intervention: Just-in-time information (JITI) app
Number of subjects: 38
Study 33273421 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited training with JITI app
Number of subjects: 38
Study 33273421 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended training with JITI app
Number of subjects: 38
Study 33273421 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 32507430 — intervention group
Group type: COMPARATOR
Intervention: Body acupressure (GB21, GB30, BL32, LI4, SP6 points for two minutes at cervical dilation of four, six, and eight centimeters)
Number of subjects: 0
Study 32507430 — intervention group
Group type: COMPARATOR
Intervention: Ear acupressure (adhesive auriculotherapy-specific Vaccaria seeds on zero, genitalia, Shen Men, thalamic, and uterine 1 and 2 acupoints, compressed every thirty minutes for thirty seconds)
Number of subjects: 0
Study 32507430 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care services)
Number of subjects: 0
Study 33966730 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel plus Me‐EGF
Number of subjects: 60
Study 33966730 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel only
Number of subjects: 60
Study 33966730 — intervention group
Group type: COMPARATOR
Intervention: No scar treatment
Number of subjects: 60
Study 32827435 — intervention group
Group type: EXPERIMENTAL
Intervention: OW semaglutide 1 mg
Number of subjects: 1405
Study 32827435 — intervention group
Group type: COMPARATOR
Intervention: OD empagliflozin 25 mg
Number of subjects: 1405
Study 35311327 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 32307515 — intervention group
Group type: EXPERIMENTAL
Intervention: POD programme (intervention group)
Number of subjects: 714
Study 32307515 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 714
Study 36126648 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostatic spray
Number of subjects: 40
Study 36126648 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemostatic methods
Number of subjects: 40
Study 33556464 — intervention group
Group type: EXPERIMENTAL
Intervention: Early AIT with intravenous anakinra (100 mg every 8 hours for 3 days, with tapering) alone
Number of subjects: 128
Study 33556464 — intervention group
Group type: EXPERIMENTAL
Intervention: Early AIT with intravenous anakinra plus glucocorticoid (intravenous methylprednisolone, 1-2 mg/kg daily, with tapering)
Number of subjects: 128
Study 33556464 — intervention group
Group type: COMPARATOR
Intervention: Late rescue treatment (anakinra or tocilizumab)
Number of subjects: 128
Study 35019020 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.12% spray
Number of subjects: 20
Study 35019020 — intervention group
Group type: COMPARATOR
Intervention: Control (sterile tap water)
Number of subjects: 20
Study 33051423 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (62±2 mL/(kg·min))
Number of subjects: 45
Study 33051423 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (72±2 mL/(kg·min))
Number of subjects: 45
Study 33051423 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (82±2 mL/(kg·min))
Number of subjects: 45
Study 33051423 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly defined)
Number of subjects: 45
Study 35007749 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment with a hook plate
Number of subjects: 124
Study 35007749 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (physiotherapy)
Number of subjects: 124
Study 35007749 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (nonoperative and operative)
Number of subjects: 124
Study 33051072 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative femoral nerve block (PreopFNB)
Number of subjects: 73
Study 33051072 — intervention group
Group type: COMPARATOR
Intervention: CONTROL (usual care)
Number of subjects: 73
Study 33930548 — intervention group
Group type: EXPERIMENTAL
Intervention: Complement genes in response to Vibrio anguillarum infection
Number of subjects: 112
Study 35581660 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmucosal diamorphine (buccal and intranasal routes)
Number of subjects: 13
Study 35581660 — intervention group
Group type: COMPARATOR
Intervention: Oral morphine
Number of subjects: 13
Study 32988292 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg
Number of subjects: 72
Study 32988292 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg
Number of subjects: 72
Study 32988292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 32763320 — intervention group
Group type: EXPERIMENTAL
Intervention: High submuscular (HSM) placement of inflatable penile prosthesis (IPP) reservoirs via the Five-Step Technique (FST)
Number of subjects: 297
Study 35686330 — intervention group
Group type: EXPERIMENTAL
Intervention: aprocitentan 12.5 mg
Number of subjects: 730
Study 35686330 — intervention group
Group type: EXPERIMENTAL
Intervention: aprocitentan 25 mg
Number of subjects: 730
Study 35686330 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 730
Study 35081947 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT) applied every 4 days, a total of three times during the study period.
Number of subjects: 50
Study 35081947 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesiotaping (placebo group).
Number of subjects: 50
Study 35081947 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT) at D30.
Number of subjects: 50
Study 35081947 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesiotaping (placebo group) at D30.
Number of subjects: 50
Study 33228621 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher perceived susceptibility of oral diseases
Number of subjects: 1207
Study 33228621 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher perceived severity of oral diseases
Number of subjects: 1207
Study 33228621 — intervention group
Group type: EXPERIMENTAL
Intervention: Flossing weekly
Number of subjects: 1207
Study 33228621 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher general anxiety level
Number of subjects: 1207
Study 33228621 — intervention group
Group type: EXPERIMENTAL
Intervention: Stronger perceived susceptibility, greater severity of oral diseases, less performing of oral health behaviors, higher DMFT score
Number of subjects: 1207
Study 33228621 — intervention group
Group type: EXPERIMENTAL
Intervention: Other HBM variables (perceived susceptibility, self‐efficacy beliefs, cues to action, perceived barriers)
Number of subjects: 1207
Study 34271982 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 16
Study 34271982 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 16
Study 34271982 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study 33031757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobitolimod 2 × 250 mg
Number of subjects: 213
Study 33031757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobitolimod 2 × 31 mg
Number of subjects: 213
Study 33031757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobitolimod 2 × 125 mg
Number of subjects: 213
Study 33031757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobitolimod 4 × 125 mg
Number of subjects: 213
Study 33031757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 35996236 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with early enteral nutrition
Number of subjects: 122
Study 35996236 — intervention group
Group type: COMPARATOR
Intervention: Early enteral nutrition
Number of subjects: 122
Study 33978491 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g/day dried plum
Number of subjects: 48
Study 33978491 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g/day dried plum
Number of subjects: 48
Study 32868360 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of ivermectin-based mass drug administration (MDA)
Number of subjects: 20
Study 32868360 — intervention group
Group type: COMPARATOR
Intervention: Two doses of ivermectin-based mass drug administration (MDA)
Number of subjects: 20
Study 32868360 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin-based MDA
Number of subjects: 20
Study 32868360 — intervention group
Group type: EXPERIMENTAL
Intervention: One-dose and two-dose MDA
Number of subjects: 20
Study 34044848 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate weight-bearing (IWB) in a walking boot and range of motion (ROM) exercise within 24 hours
Number of subjects: 0
Study 34044848 — intervention group
Group type: COMPARATOR
Intervention: Non-weight-bearing (NWB) and immobilisation in a cast for 6 weeks
Number of subjects: 0
Study 32153031 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First (HF) model of permanent supportive housing
Number of subjects: 0
Study 32153031 — intervention group
Group type: EXPERIMENTAL
Intervention: Scattered-site approach to HF
Number of subjects: 0
Study 32153031 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-site approach to HF
Number of subjects: 0
Study 32153031 — intervention group
Group type: EXPERIMENTAL
Intervention: University-community partnerships
Number of subjects: 0
Study 32153031 — intervention group
Group type: EXPERIMENTAL
Intervention: Research collaborative
Number of subjects: 0
Study 33475743 — intervention group
Group type: EXPERIMENTAL
Intervention: Haploidentical related donors
Number of subjects: 0
Study 33475743 — intervention group
Group type: COMPARATOR
Intervention: Unrelated umbilical cord blood (UCB)
Number of subjects: 0
Study 34969489 — intervention group
Group type: EXPERIMENTAL
Intervention: Math tutoring program
Number of subjects: 0
Study 34969489 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33503305 — intervention group
Group type: EXPERIMENTAL
Intervention: Pevonedistat in combination with azacitidine
Number of subjects: 30
Study 33503305 — intervention group
Group type: COMPARATOR
Intervention: Single-agent azacitidine
Number of subjects: 30
Study 32877557 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Testing (RT)
Number of subjects: 200
Study 32877557 — intervention group
Group type: COMPARATOR
Intervention: Laboratory-Based Testing (LBT)
Number of subjects: 200
Study 35298893 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 278280
Study 35298893 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal immunochemical test
Number of subjects: 278280
Study 35298893 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 278280
Study 32067657 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 61
Study 32067657 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined laser therapy and chiropractic care
Number of subjects: 61
Study 32067657 — intervention group
Group type: COMPARATOR
Intervention: Chiropractic treatment
Number of subjects: 61
Study 35864163 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-step PRK
Number of subjects: 50
Study 35864163 — intervention group
Group type: COMPARATOR
Intervention: Two-step PTK-PRK
Number of subjects: 50
Study 33189596 — intervention group
Group type: EXPERIMENTAL
Intervention: Running behavior (interval training, training with partner, physical distancing during training)
Number of subjects: 2586
Study 33189596 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms suggestive for COVID-19
Number of subjects: 2586
Study 33189596 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital admission due to COVID-19
Number of subjects: 2586
Study 33189596 — intervention group
Group type: EXPERIMENTAL
Intervention: Running behavior and running habits
Number of subjects: 2586
Study 35916430 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard methadone model of care
Number of subjects: 183
Study 35916430 — intervention group
Group type: COMPARATOR
Intervention: Flexible buprenorphine/naloxone model of care
Number of subjects: 183
Study 35916430 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (methadone and flexible buprenorphine/naloxone)
Number of subjects: 183
Study 32988670 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS-CNB
Number of subjects: 238
Study 32988670 — intervention group
Group type: COMPARATOR
Intervention: US-CNB
Number of subjects: 238
Study 32988670 — intervention group
Group type: COMPARATOR
Intervention: Incisional Biopsy
Number of subjects: 238
Study 32988670 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS-CNB vs US-CNB
Number of subjects: 238
Study 32988670 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS-CNB vs Incisional Biopsy
Number of subjects: 238
Study 36297102 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg.kg−1)
Number of subjects: 22
Study 36297102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 33722384 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules
Number of subjects: 0
Study 33722384 — intervention group
Group type: COMPARATOR
Intervention: Topical ivermectin 1% cream and placebo
Number of subjects: 0
Study 35476247 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 0
Study 35476247 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32311073 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Acute Stress Paradigm (CASP) - experimental stress manipulation
Number of subjects: 106
Study 32311073 — intervention group
Group type: COMPARATOR
Intervention: Non-stress manipulation
Number of subjects: 106
Study 33829308 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray (24 IU intranasal administration)
Number of subjects: 40
Study 33829308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32008063 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB-based intervention program (14 sessions of 1 hour during an academic year)
Number of subjects: 185
Study 32008063 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 185
Study 35397638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin (160 IU/1.6 mL)
Number of subjects: 52
Study 35397638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 34582460 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay counselor-delivered, brief transdiagnostic problem-solving intervention (4 to 5 sessions over 3 weeks) with supporting printed booklets
Number of subjects: 250
Study 34582460 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay counselor-delivered, brief transdiagnostic problem-solving intervention
Number of subjects: 250
Study 34582460 — intervention group
Group type: COMPARATOR
Intervention: Printed booklets alone (control arm)
Number of subjects: 250
Study 35198175 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine abdominal drainage
Number of subjects: 60
Study 35198175 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 60
Study 32989176 — intervention group
Group type: EXPERIMENTAL
Intervention: β-lactolin
Number of subjects: 50
Study 32989176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 35757899 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) therapy using Medtronic MiniMed™ 670G system
Number of subjects: 17
Study 32226019 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy (10,000 lux)
Number of subjects: 15
Study 32226019 — intervention group
Group type: COMPARATOR
Intervention: Dim light placebo (500 lux)
Number of subjects: 15
Study 34048286 — intervention group
Group type: EXPERIMENTAL
Intervention: MACT
Number of subjects: 48
Study 34048286 — intervention group
Group type: COMPARATOR
Intervention: MFx
Number of subjects: 48
Study 32005282 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose hUC-MSCs (2.5 million cells/kg)
Number of subjects: 72
Study 32005282 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose hUC-MSCs (5 million cells/kg)
Number of subjects: 72
Study 32005282 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional supportive treatments alone)
Number of subjects: 72
Study 32005282 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 72
Study 33064057 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin (IL)‐8 group (Group 2)
Number of subjects: 35
Study 33064057 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group (Group 1)
Number of subjects: 35
Study 33064057 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study 33438437 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab with achieved LDL-C <25 mg/dL
Number of subjects: 18924
Study 33438437 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab with achieved LDL-C 25 to 50 mg/dL
Number of subjects: 18924
Study 33438437 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab with achieved LDL-C >50 mg/dL
Number of subjects: 18924
Study 33438437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study 32728111 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of orthokeratology (OK) and 0.01% atropine solution
Number of subjects: 80
Study 32728111 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with orthokeratology (OK)
Number of subjects: 80
Study 33044364 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR) intervention for 90 seconds, thrice per week over 5 weeks
Number of subjects: 30
Study 33044364 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR) intervention
Number of subjects: 30
Study 34521367 — intervention group
Group type: EXPERIMENTAL
Intervention: CT1 study (12,000 individuals)
Number of subjects: 12000
Study 34521367 — intervention group
Group type: EXPERIMENTAL
Intervention: CT2 study (urine samples from Belgian Health Examination Survey)
Number of subjects: 12000
Study 34521367 — intervention group
Group type: COMPARATOR
Intervention: Civil relationship status
Number of subjects: 12000
Study 34521367 — intervention group
Group type: COMPARATOR
Intervention: Sexual intercourse with a casual partner
Number of subjects: 12000
Study 34521367 — intervention group
Group type: COMPARATOR
Intervention: > 3 sexual partners in the last 12 months
Number of subjects: 12000
Study 32338622 — intervention group
Group type: EXPERIMENTAL
Intervention: IT-based intervention
Number of subjects: 390
Study 32338622 — intervention group
Group type: EXPERIMENTAL
Intervention: Print-based intervention
Number of subjects: 390
Study 32338622 — intervention group
Group type: EXPERIMENTAL
Intervention: IT-based intervention with PA tracker (30% of IT group)
Number of subjects: 390
Study 32338622 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (IT-based and print-based)
Number of subjects: 390
Study 34313515 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality otoscopy simulator
Number of subjects: 0
Study 34313515 — intervention group
Group type: COMPARATOR
Intervention: Otolaryngologists
Number of subjects: 0
Study 33612341 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap group (maternal vaccination with Tdap)
Number of subjects: 540
Study 33612341 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 540
Study 33612341 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 540
Study 32641723 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Light 1.0 (biphasic exponential dimming)
Number of subjects: 0
Study 32641723 — intervention group
Group type: COMPARATOR
Intervention: Constant light
Number of subjects: 0
Study 32641723 — intervention group
Group type: COMPARATOR
Intervention: Linear dimming
Number of subjects: 0
Study 32641723 — intervention group
Group type: COMPARATOR
Intervention: Monophasic exponential dimming
Number of subjects: 0
Study 32641723 — intervention group
Group type: COMPARATOR
Intervention: Biphasic exponential dimming
Number of subjects: 0
Study 34555257 — intervention group
Group type: EXPERIMENTAL
Intervention: MBM intervention
Number of subjects: 290105
Study 34555257 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 290105
Study 34555257 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 290105
Study 33472855 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (single intravenous infusion of 8 mg/kg) plus standard care (n=65)
Number of subjects: 129
Study 33472855 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (n=64)
Number of subjects: 129
Study 32371120 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-training (four 15-min strength and four 15-min endurance bouts weekly)
Number of subjects: 290
Study 32371120 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical-training (one 60-min strength and one 60-min endurance training session weekly)
Number of subjects: 290
Study 32371120 — intervention group
Group type: COMPARATOR
Intervention: Control-group (two 60-min standard military physical training sessions weekly)
Number of subjects: 290
Study 35952460 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 120
Study 35952460 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 32618621 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure intervention
Number of subjects: 68